These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12924340)

  • 1. Pneumococcal vaccination in older adults.
    Marras TK
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924340
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal vaccination in older adults.
    Fedson DS
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924341
    [No Abstract]   [Full Text] [Related]  

  • 4. Pneumococcal vaccination in older adults.
    Hirschmann JV
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12917315
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumococcal polysaccharide vaccine may not prevent hospitalization for pneumonia in elderly individuals.
    Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
    Clin Infect Dis; 2007 Feb; 44(4):617; author reply 617-8. PubMed ID: 17260423
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS
    Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
    Fedson DS
    Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal vaccination.
    Williams RM
    Lippincotts Prim Care Pract; 1998; 2(6):625-33. PubMed ID: 9883157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN; Abrutyn E; Spaude KA; Kim A; Kirchner C; Daley J
    Clin Infect Dis; 2006 Apr; 42(8):1093-101. PubMed ID: 16575726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal vaccination in adults.
    Rashid H; Shafi S; Haworth E; Booy R
    Arch Intern Med; 2008 Mar; 168(6):666-7. PubMed ID: 18362261
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pneumococcal infections. Every second fatality within 48 hours].
    MMW Fortschr Med; 2001 Nov; 143(47):60. PubMed ID: 11791369
    [No Abstract]   [Full Text] [Related]  

  • 13. Expected benefits of pneumococcal vaccination in Canadian infants and children < 5 years old.
    Can Commun Dis Rep; 2006 Mar; 32(5):45-54. PubMed ID: 16649291
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.
    Nelson JC; Jackson M; Yu O; Whitney CG; Bounds L; Bittner R; Zavitkovsky A; Jackson LA
    Vaccine; 2008 Sep; 26(38):4947-54. PubMed ID: 18662735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thousand faces of Streptococcus pneumonia (pneumococcus) infections].
    Szabó BG; Lénárt KS; Kádár B; Gombos A; Dezsényi B; Szanka J; Bobek I; Prinz G
    Orv Hetil; 2015 Nov; 156(44):1769-77. PubMed ID: 26498896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
    Silfverdal SA; Berg S; Hemlin C; Jokinen I
    Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodology of observational studies of pneumococcal polysaccharide vaccine.
    Vila Corcoles A; Ochoa Gondar O; Llor C
    Lancet Infect Dis; 2004 Feb; 4(2):71. PubMed ID: 14871627
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics and outcomes of older adults with community-acquired pneumococcal bacteremia.
    Chi RC; Jackson LA; Neuzil KM
    J Am Geriatr Soc; 2006 Jan; 54(1):115-20. PubMed ID: 16420207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).
    Gil-Prieto R; García-García L; Alvaro-Meca A; Méndez C; García A; de Miguel AG
    Vaccine; 2011 Jan; 29(3):412-6. PubMed ID: 21111780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In brief: PCV13 for adults 65 years and older.
    Med Lett Drugs Ther; 2014 Oct; 56(1453):102. PubMed ID: 25296261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.